Europe IT Spending on Business Intelligence to 2012 Pharmaceutical Technology

Although BI in the earlier stages of drug development remains an emergent solution area in the pharmaceutical market, contextual forces such as pipeline productivity pressures and growing generic competition will drive increased spending on BI in the near future.



Report Highlights
The adoption of BI solutions will exhibit strong growth over the next five years. The Biotech segment will increase their spending on BI solutions more quickly than Big Pharma BI adoption by clinical end-user groups will demonstrate the most rapid growth compared to R&D, manufacturing and sales & marketing groups.


[Studien Infos ausblenden]

OVERVIEW 1
CATALYST 1
SUMMARY 1
METHODOLOGY 1
EUROPE IT SPENDING ON BUSINESS INTELLIGENCE SOLUTIONS IN PHARMA 3
Introduction 3
Spending by the US and Europe pharmaceutical industry on BI to 2012 4
Spending by the Big Pharma in Europe on BI to 2012 5
Spending on BI solutions by US pharmaceutical sub-segments to 2012 6
Spending by US Big Pharma on BI solutions by technology to 2012 7
Spending by Global Big Pharma on BI solutions by end-user group to 2012 8
Spending by Global Biotech on BI solutions by end-user group to 2012 9
APPENDIX 10
Definitions 10
Further reading 10
Ask the analyst 10
Datamonitor consulting 10

[Inhaltsverzeichnis ausblenden]

Table 1: Spending by US and Europe pharmaceutical industry on BI solutions to 2012 5
Table 2: Spending by the Big Pharma in Europe on BI to 2012 6
Table 3: Spending on BI solutions by Big Pharma in the UK, France, Switzerland and Germany to 2012 7
Table 4: Spending by Big Pharma in Europe on BI solutions by technology 8
Table 5: Spending by Big Pharma on BI solutions by end-user group to 2012 (US & Europe) 9
Table 6: Spending by Biotech on BI solutions by end-user group to 2012 (US) 10


Figure 1: Spending by US and Europe pharmaceutical industry on BI solutions to 2012 5
Figure 2: Spending by the Big Pharma in Europe on BI to 2012 6
Figure 3: Spending on BI solutions by Big Pharma in the UK, France, Switzerland and Germany to 2012 7
Figure 4: Spending by Big Pharma in Europe on BI solutions by technology 8
Figure 5: Spending by Big Pharma on BI solutions by end-user group to 2012 (US & Europe) 9
Figure 6: Spending by Biotech on BI solutions by end-user group to 2012 (US) 10


[Tabellenverzeichnis ausblenden]